Global Medical Ultrasound Equipment Market to Reach $8.2 Billion by 2026

A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled “Medical Ultrasound Equipment – Global Market Trajectory & Analytics”.

The report presents fresh perspectives on opportunities and challenges in a significantly transformed post COVID-19 marketplace.

Complimentary Project Preview – This is an ongoing program. Preview our research program before you make a purchase decision. We are offering a complimentary access to qualified executives driving strategy, business development, sales & marketing, and product management roles at featured companies. Previews provide deep insider access to business trends; competitive brands; domain expert profiles; and market data templates and much more. You may also build your own bespoke report using our MarketGlass™ Platform which offers thousands of data bytes without an obligation to purchase our report. Preview Registry


Global Medical Ultrasound Equipment Market to Reach $8.2 Billion by 2026
Ultrasound continues to be one of the most compelling and extensively used medical imaging modality for the healthcare community owing to its comprehensive range of advantages in the field of radiology, emergency medicine and critical care. The method is non-invasive, repeatable and affordable as well as is quick to perform, can be performed at the bedside, and avoids patient exposure to ionizing radiations.

Growth in the market is backed by factors, such as aging population, shift from X-ray and CT due to radiation concerns towards ultrasound, advanced capabilities such as 3D and 4D imaging. Favorable demographic factors in developed regions, growing access to healthcare and rising income levels of the middle class population in developing regions are enabling ultrasound equipment gain positive momentum. Future growth in ultrasound equipment market would also be driven by the strong growth in demand for portable ultrasound devices, and increasing demand from clinical applications that require point-of-care (POC) imaging. The COVID-19 has underscored the significance of ultrasound in the healthcare arena. Lung Ultrasound (LUS) is perceived as an effective medical imaging modality as COVID-19 primarily targets the respiratory system of infected people. Medical practitioners are also leveraging the technique for diagnosing and monitoring other conditions related to the heart, airways and abdomen.

Amid the COVID-19 crisis, the market for Medical Ultrasound Equipment estimated at US$6.6 Billion in the year 2022, is projected to reach a revised size of US$8.2 Billion by 2026, growing at a CAGR of 5% over the analysis period. Diagnostic, one of the segments analyzed in the report, is projected to record 4.8% CAGR and reach US$5.5 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Therapeutic segment is readjusted to a revised 5.4% CAGR for the next 7-year period. The growth of ultrasound medical devices in the diagnostics arena can also be attributed to the benefits offered over computed tomography (CT), Magnetic Resonance Imaging (MRI) and other imaging tools, in terms of safety, price, and effectiveness. Ultrasound devices do not include any ionizing radiation, and are therefore much safer to use when compared to other imaging tools. An ultrasound also costs less when compared to a CT or an MRI. The technology also finds therapeutic applications, such as in tissue ablation, bone repair and growth, and cataract treatment. Researchers globally are using ultrasonic waves to perform non-invasive acoustic, or “bloodless” surgery, and to stop internal bleeding in trauma patients as well as to control the delivery of drugs or other molecules to targeted sites in the body.

The U.S. Market is Estimated at $1.3 Billion in 2022, While China is Forecast to Reach $1.9 Billion by 2026
The Medical Ultrasound Equipment market in the U.S. is estimated at US$1.3 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.9 Billion by the year 2026 trailing a CAGR of 6.4% over the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.9% and 4.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR. Strong economic growth, increasing healthcare spending, improved standard of healthcare facilities are expected to fuel demand for new equipment in developing markets. Aging population and rising incidence of chronic illnesses are driving demand for ultrasound systems in these markets.

Contrast Agents Expand Ultrasound Applications
While x-ray contrast media depend on chemical formulation to take up x-rays, ultrasound contrast media are pharmaceuticals, which improve a reverberation from an ultrasound beam due to its physical properties. So far, the most efficient formulations developed in case of ultrasound use microbubbles of gas, which is a difficult process. The bubbles need to be small to red blood cells so that there is no blockage of capillaries, further, small bubbles are quickly soluble in body fluids or get absorbed by body’s normal defense mechanisms against blood-borne microparticles. All the initial agents used microbubbles of air, which carry limited lifespan after being injected into the body as air bubbles dissolved rapidly in blood. The innovative ultrasound contrast agents are in the developmental and evaluation stages in clinical trials, waiting for the approval. The latest agents use varied methods to ensure longer bubble survival time in body, together with the use of less-soluble gases, protective bubble coatings and formulations, which liberate bubbles slowly.

Enhancing the usefulness of diagnostic ultrasound scans and procedures, ultrasound contrast media have been developed for specific organ imaging. For instance, sonographic assessment of the upper GI tract is complemented by injecting degassed water to improve the GI tract’s visibility on the screen.

Certain types of oral ultrasound contrast agents are also used to adsorb and displace stomach and bowel gas. “SonoRx” from Bracco is one such oral capsule containing simethicone-coated cellulose for homogeneous transmission of sound through the contrast-filled stomach. Vascular contrast agents complement echocardiographic examinations by producing echoes within the heart. Vascular contrast agents contain microbubbles as small as 5 mm in diameter, to help its penetration through the lung capillaries and into systemic circulation. The contrast agents are additionally insulated against dissolution, instability and coalescence.
Microbubbles/ultrasound contrast agents can be described as small spherical bubbles, which include three phases namely innermost gas phase, the shell material enclosing the gas phase, and outermost gas or liquid phase. The microbubbles can respond to ultrasound, thus enabling its use in ultrasound imaging and research applications. Microbubble contrast agents are considered as safe and effective agents for use in clinical practices, thus presenting considerable growth opportunities for the diagnostic imaging agents market. Growth in the microbubbles/ultrasound contrast agents market is being fostered by the increasing advantages of using ultrasound technology compared to other options, an aging global population and the subsequent increase in chronic disease prevalence, and growing number of diagnostics and image guided procedures being performed, and rapid pace of technology advances in the space. More
MarketGlass™ Platform
Our MarketGlass™ Platform is a free full-stack knowledge center that is custom configurable to today’s busy business executive’s intelligence needs! This influencer driven interactive research platform is at the core of our primary research engagements and draws from unique perspectives of participating executives worldwide. Features include – enterprise-wide peer-to-peer collaborations; research program previews relevant to your company; 3.4 million domain expert profiles; competitive company profiles; interactive research modules; bespoke report generation; monitor market trends; competitive brands; create & publish blogs & podcasts using our primary and secondary content; track domain events worldwide; and much more. Client companies will have complete insider access to the project data stacks. Currently in use by 67,000+ domain experts worldwide.
About Global Industry Analysts, Inc. & StrategyR™
Global Industry Analysts, Inc., is a renowned market research publisher the world’s only influencer driven market research company. Proudly serving more than 42,000 clients from 36 countries, GIA is recognized for accurate forecasting of markets and industries for over 33 years.
This article was shared with Prittle Prattle News as a Press Release.
Must Read – Culture D2C startup 
Follow Us: Facebook Instagram | Twitter YouTube | LinkedIn Pinterest Tumblr

Related Posts

1 of 428